Literature DB >> 21533710

Brain white matter lesions in migraine: what's the meaning?

Bruno Colombo1, D Dalla Libera, G Comi.   

Abstract

Migraine has been associated with structural brain damage. Several studies have reported an association between migraine and brain white matter lesions or clinically silent infarct-like abnormalities in the posterior circulation territory. The origin of these lesions is still unclear. The cause is commonly interpreted as ischemic, which is consistent with the association of migraine, particularly with aura, with vascular risk factors. The relationship between increased volume of white matter hyperintensities and a history of severe headache per se is under debate. The clinical relevance of this brain damage deserves further investigations even if an association between cognitive impairment and migraine or headache of any type is not confirmed.

Entities:  

Mesh:

Year:  2011        PMID: 21533710     DOI: 10.1007/s10072-011-0530-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

Authors:  G E Tietjen; M Day; L Norris; S Aurora; A Halvorsen; L R Schultz; S R Levine
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

2.  Evidence for cortical functional changes in patients with migraine and white matter abnormalities on conventional and diffusion tensor magnetic resonance imaging.

Authors:  Maria A Rocca; Bruno Colombo; Elisabetta Pagani; Andrea Falini; Maria Codella; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

3.  Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Authors:  M Schwerzmann; K Nedeltchev; F Lagger; H P Mattle; S Windecker; B Meier; C Seiler
Journal:  Neurology       Date:  2005-09-07       Impact factor: 9.910

4.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

5.  Vanishing cerebellar infarcts in a migraine patient.

Authors:  T D Rozen
Journal:  Cephalalgia       Date:  2007-06       Impact factor: 6.292

6.  Magnetic resonance imaging of the brain in patients with migraine.

Authors:  H Igarashi; F Sakai; S Kan; J Okada; Y Tazaki
Journal:  Cephalalgia       Date:  1991-05       Impact factor: 6.292

Review 7.  Migraine as a systemic vasculopathy.

Authors:  G E Tietjen
Journal:  Cephalalgia       Date:  2009-09       Impact factor: 6.292

8.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

Review 9.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26

10.  Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study.

Authors:  Tobias Kurth; Shajahal Mohamed; Pauline Maillard; Yi-Cheng Zhu; Hugues Chabriat; Bernard Mazoyer; Marie-Germaine Bousser; Carole Dufouil; Christophe Tzourio
Journal:  BMJ       Date:  2011-01-18
View more
  9 in total

Review 1.  From neuroimaging to clinical setting: what have we learned from migraine pain?

Authors:  Bruno Colombo; Gloria Dalla Costa; Dacia Dalla Libera; Giancarlo Comi
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Migraine, cerebrovascular disease and the metabolic syndrome.

Authors:  Alexandra J Sinclair; Manjit Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

3.  Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.

Authors:  Anja Bumb; Burkhard Seifert; Stephan Wetzel; Reto Agosti
Journal:  Springerplus       Date:  2013-08-10

4.  Vestibular migraine with Wallenberg syndrome: a case report.

Authors:  Ying Xin; Junyi Fu; Longchang Xie; Jie Yang; Guanhao Ke
Journal:  BMC Neurol       Date:  2020-05-25       Impact factor: 2.474

5.  Purinergic Profiling of Regulatory T-cells in Patients With Episodic Migraine.

Authors:  Dilyara Nurkhametova; Igor Kudryavtsev; Olga Khayrutdinova; Maria Serebryakova; Rashid Altunbaev; Tarja Malm; Rashid Giniatullin
Journal:  Front Cell Neurosci       Date:  2018-09-25       Impact factor: 5.505

6.  Altered Macular Vasculature in Migraine Patients without Aura: Is It Associated with Ocular Vasculature and White Matter Hyperintensities?

Authors:  Nurdan Gamze Taşlı; Alevtina Ersoy
Journal:  J Ophthalmol       Date:  2020-04-13       Impact factor: 1.909

7.  Risk factors of white matter hyperintensities in migraine patients.

Authors:  Jasem Yousef Al-Hashel; Raed Alroughani; Khaled Gad; Lamiaa Al-Sarraf; Samar Farouk Ahmed
Journal:  BMC Neurol       Date:  2022-04-29       Impact factor: 2.903

8.  White matter hyperintensities and self-reported depression in a sample of patients with chronic headache.

Authors:  Gianluca Serafini; Maurizio Pompili; Marco Innamorati; Andrea Negro; Martina Fiorillo; Dorian A Lamis; Denise Erbuto; Francesco Marsibilio; Andrea Romano; Mario Amore; Lidia D'Alonzo; Alessandro Bozzao; Paolo Girardi; Paolo Martelletti
Journal:  J Headache Pain       Date:  2012-10-19       Impact factor: 7.277

Review 9.  New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

Authors:  Claudio Tana; Emmanuele Tafuri; Marco Tana; Paolo Martelletti; Andrea Negro; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini; Andrea Mezzetti; Maria Adele Giamberardino
Journal:  J Headache Pain       Date:  2013-02-01       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.